coding INBSP koncentruje się na tworzeniu i wdrażaniu precyzyjnych regulacji prawnych dotyczących psylocybiny i MDMA, wzorowanych na międzynarodowych modelach, takich jak system australijski. Naszym celem jest uwzględnienie tych substancji w ramach kontrolowanego i bezpiecznego systemu medycznego (nie do podania w domu ani w innych miejscach poza kontekstem klinicznym).
The content, information, opinions, and viewpoints contained in these educational materials are those of the authors or contributors of such materials. While the American Society of Transplantation (AST) and its committees take great care to screen the credentials of the contributors and make every attempt to review the contents, AST MAKES NO WARRANTY, EXPRESSED OR IMPLIED, as to the completeness or accuracy of the content contained in the educational materials or on this website. The reader of these materials uses these materials at his or her own risk, and AST shall not be responsible for any errors, omissions, or inaccuracies in these materials, whether arising through negligence, oversight, or otherwise. Reliance on any information appearing on this site is strictly at your own risk.